Akums will hold 51 per cent while GRZ, though its nominated state instrumentality, will hold 49 per cent in this joint venture
Akums and The Government of The Republic of Zambia (GRZ), have announced a partnership to set up a manufacturing facility in Zambia to provide high-quality and affordable generic medicines for patients in Zambia.
The partnership will involve setting up a state-of-the-art manufacturing facility in Zambia to manufacture and supply medicines in Zambia. The JV also, in the future, will export to neighboring African countries like Zimbabwe, Namibia, Botswana, Malawi, Tanzania, Mozambique etc.
The manufacturing facility will be housed in a newly formed Joint venture company (JV), which will be headquartered in Zambia. Akums will hold 51 per cent while GRZ, though its nominated state instrumentality, will hold 49 per cent in this joint venture. The JV will be managed by a Board with representatives from both partners. The JV is expected to be established by Q3 FY 26, post which the construction of the facility will begin.
Commercial supplies from the facility are expected to begin in Q3 FY 28, subject to the timely establishment of the facility and regulatory approvals for the facility and products. The facility will manufacture tablets, hard gelatin capsules, liquids, injectables, as well as beta-lactam products. Both partners will contribute in the establishment and operationalisation of the facility in the ratio of their shareholding.
To fulfill the current national healthcare needs, the Govt of Zambia has also committed to purchase essential medicines from Akums’ facilities in India to Zambia. The supply will be a minimum of $25 million annually in calendar years 2026 and 2027.
“We are proud to partner with GRZ to deliver high-quality, affordable medicines manufacturing for the Zambian healthcare system. This is our first manufacturing partnership outside India and aligns with the vision of becoming a global CMDO,” said Sanjeev Jain, Managing Director, Akums.
